Department of Laboratory Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, and People's Hospital of Henan University, Zhengzhou, Henan, China.
Department of Laboratory Medicine, Gongyi City People's Hospital, Zhengzhou, Henan, China.
J Glob Antimicrob Resist. 2022 Jun;29:68-73. doi: 10.1016/j.jgar.2022.01.029. Epub 2022 Feb 5.
To identify the carbapenemase and colistin resistance genes and epidemiological status of carbapenem-resistant Enterobacterales (CRE) among 7 secondary and 11 tertiary hospitals in Henan province, China.
CRE isolates and clinical data of infected patients were collected from 7 secondary and 11 tertiary hospitals in Henan from July to September 2019 and analysed retrospectively. Polymerase chain reaction (PCR) and gene sequencing were performed to detect carbapenemase and colistin resistance genes; multilocus sequence typing was also performed.
In total, 238 nonduplicate CRE isolates were collected mainly from the respiratory tract (54.20%) and blood (18.91%) of CRE-infected patients, half of them aged >65 years (45.80%). Carbapenem-resistant Klebsiella pneumoniae (CRKP) was the most common CRE (184 isolates, 77.31%) with constituent ratios of 84.38% and 72.54% in secondary and tertiary hospitals, respectively. In 184 CRKP isolates, bla (89.13%) was the dominant carbapenemase gene, and ST11 (71.74%) was the most prevalent sequence type (ST), with constituent ratios of 83.95% and 62.14% in secondary and tertiary hospitals, respectively. In 29 carbapenem-resistant Escherichia coli (CREC) isolates, bla (58.62%) and ST2 (31.03%) were prevalent. Four CRKP isolates and one CREC isolate were colistin-resistant and carried the plasmid-mediated mcr-1 gene.
Our results showed a wide spread of CRKP-ST11 with KPC-2 carbapenemase in the analysed 18 hospitals. The CRKP constituent ratio, CRKP-STs, and CREC carbapenemase genes between secondary and tertiary hospitals showed significant differences. The emergence of a colistin-resistant CRKP with plasmid-mediated resistance gene mcr-1 is of serious concern due to the limited treatment options.
在中国河南省的 7 家二级医院和 11 家三级医院中,鉴定耐碳青霉烯肠杆菌科(CRE)的碳青霉烯酶和多黏菌素耐药基因以及其流行病学状况。
2019 年 7 月至 9 月,从河南省的 7 家二级医院和 11 家三级医院收集耐碳青霉烯肠杆菌科 CRE 分离株和感染患者的临床数据,进行回顾性分析。采用聚合酶链反应(PCR)和基因测序检测碳青霉烯酶和多黏菌素耐药基因;多位点序列分型(MLST)。
共收集了 238 例非重复耐碳青霉烯肠杆菌科 CRE 分离株,主要来自耐碳青霉烯肠杆菌科 CRE 感染患者的呼吸道(54.20%)和血液(18.91%),其中一半年龄>65 岁(45.80%)。耐碳青霉烯肺炎克雷伯菌(CRKP)是最常见的耐碳青霉烯肠杆菌科 CRE(184 株,77.31%),二级和三级医院的构成比分别为 84.38%和 72.54%。在 184 株 CRKP 分离株中,bla(89.13%)是优势碳青霉烯酶基因,ST11(71.74%)是最常见的序列型(ST),二级和三级医院的构成比分别为 83.95%和 62.14%。在 29 株耐碳青霉烯大肠埃希菌(CREC)分离株中,bla(58.62%)和 ST2(31.03%)较为常见。4 株 CRKP 分离株和 1 株 CREC 分离株对多黏菌素耐药,携带可移动质粒介导的 mcr-1 基因。
我们的研究结果表明,在分析的 18 家医院中,广泛存在携带 KPC-2 碳青霉烯酶的 CRKP-ST11。二级和三级医院之间的耐碳青霉烯肠杆菌科 CRE 构成比、CRKP-STs 和 CREC 碳青霉烯酶基因存在显著差异。由于治疗选择有限,出现携带可移动质粒介导耐药基因 mcr-1 的耐碳青霉烯肠杆菌科 CRE 引起了严重关注。